Last updated: 1 August 2024 at 3:45pm EST

Michael D. Witzeman CPA, MBA Net Worth




The estimated Net Worth of Michael D Witzeman is at least $16.3 Миллион dollars as of 31 July 2024. Mr Witzeman owns over 7,948 units of Chemed stock worth over $6,244,525 and over the last 7 years he sold CHE stock worth over $9,064,114. In addition, he makes $991,144 as VP & Controller at Chemed.

Mr MBA CHE stock SEC Form 4 insiders trading

Mr has made over 28 trades of the Chemed stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 7,948 units of CHE stock worth $3,749,390 on 31 July 2024.

The largest trade he's ever made was exercising 8,000 units of Chemed stock on 4 November 2020 worth over $1,855,280. On average, Mr trades about 2,157 units every 66 days since 2017. As of 31 July 2024 he still owns at least 11,009 units of Chemed stock.

You can see the complete history of Mr Witzeman stock trades at the bottom of the page.





Mr. Michael D. Witzeman CPA, MBA biography

Michael D. Witzeman CPA, MBA is the VP & Controller at Chemed.

What is the salary of Mr MBA?

As the VP & Controller of Chemed, the total compensation of Mr MBA at Chemed is $991,144. There are 8 executives at Chemed getting paid more, with Kevin McNamara having the highest compensation of $10,019,800.



How old is Mr MBA?

Mr MBA is 50, he's been the VP & Controller of Chemed since . There are 16 older and 3 younger executives at Chemed. The oldest executive at Chemed Corp. is Walter Krebs, 86, who is the Independent Director.

What's Mr MBA's mailing address?

Michael's mailing address filed with the SEC is 2600 CHEMED CENTER, 255 EAST FIFTH STREET, CINCINNATI, OH, 45202.

Insiders trading at Chemed

Over the last 22 years, insiders at Chemed have traded over $138,634,486 worth of Chemed stock and bought 2,293 units worth $478,104 . The most active insiders traders include Kevin J Mcnamara, David Patrick Williams и Spencer S Lee. On average, Chemed executives and independent directors trade stock every 19 days with the average trade being worth of $4,438,497. The most recent stock trade was executed by Nicholas Michael Westfall on 9 September 2024, trading 1,713 units of CHE stock currently worth $975,297.



What does Chemed do?

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.



Complete history of Mr Witzeman stock trades at Chemed

инсайдер
Транзакция
Транзакция
Общая стоимость
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $3,749,390
31 Jul 2024
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $454,509
7 May 2024
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $1,704,321
20 Mar 2024
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $253,950
16 Feb 2024
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $1,363,527
8 Nov 2023
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $344,615
17 Feb 2023
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $366,874
10 Nov 2022
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $2,116,230
3 Nov 2022
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $412,414
18 Feb 2022
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $531,630
19 Feb 2021
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $1,300,000
17 Dec 2020
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $1,855,280
4 Nov 2020
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $1,000,000
3 Aug 2020
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $542,057
21 Feb 2020
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $1,087,500
4 Dec 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $905,712
21 Nov 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $1,880,943
16 Aug 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $954,240
12 Aug 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $241,080
12 Mar 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $353,673
22 Feb 2019
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $549,332
24 Aug 2018
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $249,635
30 Jul 2018
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $313,000
2 May 2018
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $452,788
24 Apr 2018
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $249,114
16 Feb 2018
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $250,000
4 Dec 2017
Michael D Witzeman
Вице-президент и Главный финансовый директор
Продажа $371,065
16 Nov 2017
Michael D Witzeman
Вице-президент и Главный финансовый директор
Реализация опциона $629,440
6 Nov 2017


Chemed executives and stock owners

Chemed executives and other stock owners filed with the SEC include: